{"pmid":32297717,"title":"COVID-19: Humanitarian and Health Care Crisis in a Third World Country.","text":["COVID-19: Humanitarian and Health Care Crisis in a Third World Country.","J Clin Psychiatry","Andrade, Chittaranjan","32297717"],"journal":"J Clin Psychiatry","authors":["Andrade, Chittaranjan"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297717","week":"202016|Apr 13 - Apr 19","doi":"10.4088/JCP.20com13383","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651206418432,"score":8.233237,"similar":[{"pmid":32118371,"pmcid":"PMC7063555","title":"The third coronavirus epidemic in the third millennium: what's next?","text":["The third coronavirus epidemic in the third millennium: what's next?","Croat Med J","Civljak, Rok","Markotic, Alemka","Kuzman, Ilija","32118371"],"journal":"Croat Med J","authors":["Civljak, Rok","Markotic, Alemka","Kuzman, Ilija"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32118371","week":"202010|Mar 02 - Mar 08","source":"PubMed","weight":0,"_version_":1663352134342541312,"score":57.7812},{"pmid":32215807,"title":"COVID-19: opportunity arises from a world health crisis.","text":["COVID-19: opportunity arises from a world health crisis.","J Pharmacokinet Pharmacodyn","Bonate, Peter L","32215807"],"journal":"J Pharmacokinet Pharmacodyn","authors":["Bonate, Peter L"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215807","week":"202013|Mar 23 - Mar 29","doi":"10.1007/s10928-020-09681-5","link_comment_for":"32171059","source":"PubMed","weight":0,"_version_":1663352134963298305,"score":53.01519},{"pmid":32199457,"pmcid":"PMC7085188","title":"Responding to the COVID-19 pandemic in complex humanitarian crises.","text":["Responding to the COVID-19 pandemic in complex humanitarian crises.","Int J Equity Health","Poole, Danielle N","Escudero, Daniel J","Gostin, Lawrence O","Leblang, David","Talbot, Elizabeth A","32199457"],"journal":"Int J Equity Health","authors":["Poole, Danielle N","Escudero, Daniel J","Gostin, Lawrence O","Leblang, David","Talbot, Elizabeth A"],"date":"2020-03-23T11:00:00Z","year":2020,"_id":"32199457","week":"202013|Mar 23 - Mar 29","doi":"10.1186/s12939-020-01162-y","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352133614829568,"score":49.437187},{"pmid":32269357,"title":"COVID-19 in humanitarian settings and lessons learned from past epidemics.","text":["COVID-19 in humanitarian settings and lessons learned from past epidemics.","Nat Med","Lau, Ling San","Samari, Goleen","Moresky, Rachel T","Casey, Sara E","Kachur, S Patrick","Roberts, Leslie F","Zard, Monette","32269357"],"journal":"Nat Med","authors":["Lau, Ling San","Samari, Goleen","Moresky, Rachel T","Casey, Sara E","Kachur, S Patrick","Roberts, Leslie F","Zard, Monette"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269357","week":"202015|Apr 06 - Apr 12","doi":"10.1038/s41591-020-0851-2","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663620083094650883,"score":47.140194},{"pmid":32196933,"title":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic.","text":["Coronaviruses and immunosuppressed patients. The facts during the third epidemic.","Following the outbreak in China, the Lombardy region of Italy has become one of the areas of highest incidence of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). As the outbreak grew to a pandemic, many centres worldwide raised the concern that immunocompromised patients may be at high risk of developing a severe respiratory disease called COVID-19. Unlike common viral agents (such as Adenovirus, Rhinovirus, Norovirus, Influenza, Respiratory Syncytial Virus), Coronaviruses have not shown to cause a more severe disease in immunosuppressed patients. For this family of viruses the host innate immune response appears the main driver of lung tissue damage during infection.","Liver Transpl","D'Antiga, Lorenzo","32196933"],"abstract":["Following the outbreak in China, the Lombardy region of Italy has become one of the areas of highest incidence of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). As the outbreak grew to a pandemic, many centres worldwide raised the concern that immunocompromised patients may be at high risk of developing a severe respiratory disease called COVID-19. Unlike common viral agents (such as Adenovirus, Rhinovirus, Norovirus, Influenza, Respiratory Syncytial Virus), Coronaviruses have not shown to cause a more severe disease in immunosuppressed patients. For this family of viruses the host innate immune response appears the main driver of lung tissue damage during infection."],"journal":"Liver Transpl","authors":["D'Antiga, Lorenzo"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196933","week":"202012|Mar 16 - Mar 22","doi":"10.1002/lt.25756","keywords":["Coronavirus","SARS","SARS-CoV-2,COVID-19","children","immunosuppression","liver","transplantation","viral infection"],"source":"PubMed","locations":["Norovirus","Rhinovirus","China","Italy","Coronaviruses","Lombardy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Mechanism"],"weight":1,"_version_":1663352133500534784,"score":43.80521}]}